National Payton Slaymaker Day honors the inspiring story of a young girl whose strength touched hearts across the United States.
Diagnosed with diffuse intrinsic pontine glioma (D.I.P.G.), a rare, aggressive brain cancer, Payton Slaymaker faced her journey with remarkable positivity.
Her spirit and courage resonated with many, inspiring people nationwide to unite in her memory. This day brings her story to light, allowing her bravery and joy to be remembered and celebrated, especially by those touched by similar challenges.
Beyond honoring Payton, the day raises critical awareness of D.I.P.G., a disease that remains underfunded and devastating to young lives.
National Payton Slaymaker Day shines a spotlight on the need for more research and support, offering a moment for people to learn, donate, and rally for future advancements in cancer treatment.
How to Celebrate National Payton Slaymaker Day
Observing National Payton Slaymaker Day can be heartfelt, memorable, and even a little fun. Here are some creative ideas to honor Payton’s legacy while raising awareness of childhood brain cancer.
Share Payton’s Story
Spread her message online or in person! Post about Payton’s story on social media or with family and friends.
Raising awareness for diffuse intrinsic pontine glioma (D.I.P.G.) can help make a difference in understanding and supporting research for this disease.
Get Crafty with a Tribute
Uniquely express yourself. Draw, paint, or make a small sculpture inspired by Payton’s favorite things, like music, dance, or friendship.
Sharing these creations as a community tribute can bring people closer together in her memory.
Support D.I.P.G. Research
Donate to organizations focused on funding D.I.P.G. research. Every contribution helps move us closer to better treatment options.
Whether it’s a local charity or a well-known cancer research foundation, each donation adds value.
Hold a Movie Night Fundraiser
Host a cozy movie night with friends or neighbors. Set up a small donation jar and enjoy Payton’s favorite movies or feel-good classics.
It’s a warm way to gather, relax, and remember her positive spirit while raising funds for a good cause.
Share a Smile
Sometimes, the simplest gestures mean the most. Payton was known for her kind heart. Reach out to others, help a neighbor, or simply share a smile.
Acts of kindness in her memory spread her warmth and joy even further.
National Payton Slaymaker Day Timeline
First clinical description of pontine gliomas in children
Neurologists in the early 20th century began publishing detailed case reports of intrinsic tumors of the pons in children, laying the groundwork for what would later be classified as diffuse intrinsic pontine glioma.
Introduction of cranial CT scanning in pediatric brain tumor diagnosis
The clinical rollout of computed tomography allowed physicians to noninvasively visualize brainstem masses in children for the first time, improving recognition and basic characterization of tumors that would later be labeled DIPG.
MRI becomes the standard imaging tool for brainstem tumors
Magnetic resonance imaging rapidly replaces CT for evaluating pediatric brain tumors, giving clinicians clearer views of infiltrative tumors in the pons and enabling more accurate diagnosis of diffuse intrinsic pontine glioma without surgical biopsy.
Evidence that radiotherapy offers only temporary relief for DIPG
Clinical outcome studies in the early 1990s show that conventional external beam radiation can briefly shrink diffuse pontine tumors and improve symptoms, but nearly all children relapse within months, underscoring the need for new treatments.
Landmark discovery of H3K27M mutations in DIPG
Genomic analyses reveal recurrent mutations in histone H3 genes (H3.3 and H3.1) in most diffuse intrinsic pontine gliomas, defining a new molecular subtype and shifting research toward epigenetic drivers of these lethal pediatric brain tumors.
Childhood brain tumors surpass leukemia as the leading cause of U.S. cancer death in kids
An analysis of national mortality data finds that brain tumors have become the top cause of cancer-related death among American children, focusing attention on deadly entities like DIPG that have seen little survival improvement in decades.
WHO formally recognizes “diffuse midline glioma, H3 K27M‑mutant”
The World Health Organization’s revision of central nervous system tumor classifications introduces diffuse midline glioma, H3 K27M‑mutant, which includes most DIPG cases, standardizing diagnosis and supporting more targeted clinical trials.
History of National Payton Slaymaker Day
National Payton Slaymaker Day began as a heartfelt tribute to Payton Slaymaker, a brave girl from Indiana. Payton, diagnosed with diffuse intrinsic pontine glioma (D.I.P.G.) in 2019, faced her illness with remarkable courage.
After her passing in 2021, her community wanted to honor her strength and spirit. They created this day to remember her life and raise awareness about D.I.P.G., a rare, aggressive form of brain cancer affecting children.
The idea for this day came from Payton’s family and supporters who saw how her story touched lives across the country. Her journey inspired people far beyond her hometown, leading them to join together in support of families affected by childhood cancer.
By establishing a national day, they aimed to spotlight both Payton’s legacy and the urgent need for research into this devastating disease.
National Payton Slaymaker Day is now observed each year, drawing attention to the challenges families face when dealing with D.I.P.G.
It also highlights the importance of funding for research, as treatments remain limited for children diagnosed with this illness. The day brings communities together in both remembrance and hope.
Payton’s story shows that this special day encourages people to contribute in meaningful ways.
From donations to simple acts of kindness, National Payton Slaymaker Day emphasizes the impact one young life can have. Each year, her legacy grows, spreading awareness and kindness in her name.
DIPG Facts: Understanding a Rare and Aggressive Childhood Brain Tumor
Diffuse intrinsic pontine glioma (DIPG) is one of the most challenging pediatric brain cancers, affecting a critical area that controls essential life functions.
These facts highlight what makes DIPG unique, why it is so difficult to treat, and why continued research and awareness are vital for improving outcomes for children and their families.
DIPG Primarily Attacks a Tiny but Vital Part of the Brain
Diffuse intrinsic pontine glioma grows within the pons, a section of the brainstem that helps control breathing, heart rate, sleep, and facial movement.
Because the tumor cells are interwoven with this critical tissue rather than forming a distinct mass, surgeons cannot safely remove it without risking fatal damage to basic life functions.
A Single Genetic Change Drives Many DIPG Tumors
Many DIPG tumors carry a characteristic mutation in genes that code for histone H3, often called H3K27M.
This mutation disrupts how DNA is packaged and how genes are switched on and off, which in turn helps cancer cells grow and resist standard treatments. Its discovery in the 2010s reshaped scientists’ understanding of DIPG as a distinct “epigenetic” disease.
Childhood Brain Tumors Differ Biologically from Adult Brain Cancers
Pediatric high-grade gliomas like DIPG are not simply “smaller versions” of adult brain tumors.
They tend to arise in different locations, carry different genetic mutations, and respond differently to therapy.
These differences mean drugs that work in adults with brain cancer often fail in children, underscoring the need for child‑specific research.
Radiation Is Still the Mainstay of DIPG Treatment
Despite decades of work, focal radiation therapy remains the only treatment that reliably offers temporary symptom relief and a modest extension of life for most DIPG patients.
Chemotherapy and targeted drugs have been tested in many clinical trials, but none have yet produced a clear, long‑term survival benefit when added to radiation.
Most Childhood Cancer Funding Bypasses Brain Tumors
In the United States, pediatric cancers receive only a small fraction of overall federal cancer research funding, and brain tumors get just a slice of that amount.
Analyses by advocacy groups drawing on National Cancer Institute data show that while brain tumors are the leading cause of cancer death in children, they receive substantially less research investment than many adult cancers.
Families Face Lasting Emotional and Financial Strain after a Child’s Brain Cancer
Research on parents of children with brain tumors shows high rates of anxiety, depression, and post‑traumatic stress, both during treatment and after a child’s death or survivorship.
Caregivers often reduce work hours or leave jobs entirely, leading to long‑term financial hardship on top of medical expenses and travel for specialized care.
Social Media Has Changed How Childhood Illness Stories Spread
Studies of “carepages” and social media updates for seriously ill children find that online storytelling can mobilize large networks of emotional support and fundraising in a short time.
These digital communities often extend far beyond a child’s hometown, helping families feel less isolated while also raising public awareness of rare pediatric diseases such as DIPG.
